Pfizer pauses request for FDA authorization of COVID vaccines for kids under 5, awaits more trial data
February 11, 2022 at 16:57 PM EST
Pfizer-BioNTech's 3-dose vaccine trial for children 6 months to five years old is expected to be available in April
